Perbedaan Indofarma Tbk. dan Indo Straits Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Indo Straits Tbk. diperdagangkan di Rp260 (kapitalisasi pasar 144,14 M, volume 24 jam 66,9 rb). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Indo Straits Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | PTIS | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 144,14 M |
Volume | — | 66,9 rb |
Lot | — | 669 |
Perputaran | — | 17,5 jt |
Harga Rata-rata | — | 261,64 |
Nilai Transaksi | — | 17,5 jt |
Harga Ekuilibrium Indikatif | — | 260 |
Volume Ekuilibrium Indikatif | — | 20 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Selengkapnya di halaman PTIS →